CSL to lift the hood on its big Vifor acquisition on Monday

CSL investors have been waiting to hear about the blood product giant’s strategy for Vifor after a $US12bn acquisition.

Related Keywords

Australia , United States , Australian , America , American , Vifor Pharma , Rhett Whyman , Vifor Ferinject , Andrew Paine , Jefferie David Stanton , Abrdn Michelle Lopez , Fresenius , European Commission , Drug Administration , Michelle Lopez , Australian Financial Review , Shane Storey , David Stanton ,